Compare stocks

BioArctic AB is a Swedish biopharmaceutical company focusing on developing treatments for central nervous system disorders. The company is notably engaged in the research and development of therapies for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Founded in 2003, BioArctic collaborates with academic institutions and global pharmaceutical companies to advance its innovative approaches. The company is headquartered in Stockholm, Sweden, and leverages its strategic partnerships and scientific expertise to address unmet medical needs in its chosen field. BioArctic's competitive strengths include its proprietary technology platforms and strong intellectual property portfolio.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.